Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform (Perseverance Study)

Acute Infection Clinical Trial

Official title:
A Prospective Multi-center Sample Collection Study for Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform ("Perseverance" Study)

Status Completed

Clinical Trial Summary

This is a Prospective, multi-center, sample collection study enrolling pediatric and adult subjects presented to the ED/Urgent care, with symptoms consistent with acute bacterial or viral infection will be recruited according to eligibility criteria. The study is designed to measure the MeMed BV®️ score in whole blood and serum samples and demonstrate the equivalence between the two matrices. Patients will be managed according to the current standard of care per standard institutional procedures.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Acute Infection

Clinical Trial Details

NCT number	NCT05439551
Study type	Observational
Source	MeMed Diagnostics Ltd.
Contact
Status	Completed
Phase
Start date	February 11, 2022
Completion date	September 29, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04690569` - Establish MeMed BV™ Performance for Differentiating Bacterial From Viral Infection in Suspected Acute Infection Patients (APOLLO STUDY)
Completed	`NCT04182906` - Pediatric ACEs Screening and Resiliency Study	N/A
Completed	`NCT04686292` - Diagnostic Accuracy of Urine Flow Cytometry in Excluding Bacteruria
Completed	`NCT03494790` - Markers of Inflammation and Metabolism in the ER
Completed	`NCT05293977` - Short-Term Use of Antibiotics and Adherence Level	N/A
Recruiting	`NCT05758246` - Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial	Phase 2
Completed	`NCT06040684` - Development of Antibodies Against Transplant Kidney After Infection